ABSTRACT

COVID-19 had different waves within thesame country. The spread rate and severity showed different properties within the COVID-19 different waves. The present work aims to compare the spread and the severity of the different waves using the available data of confirmed COVID-19 cases and death cases. Real-datasets collected from the Johns Hopkins University Center for Systems Science were used to perform a comparative study between COVID-19 different waves in 12 countries with the highest total performed tests for SARS-Cov-2 detection in the world (Italy, Brazil, Japan, Germany, Spain, India, USA, UAE, Poland, Colombia, Turkey, and Switzerland). The total number of confirmed cases and death cases in different waves of COVID-19 were compared to that of the previous one for equivalent periods. The total number of death cases in each wave was presented as a percentage of the total number of confirmed cases for the same periods. In all the selected 12 countries, wave 2 had a much higher number of confirmed cases than that in wave 1. However, the death cases increase was not comparable with that of the confirmed cases to the extent that some countries had lower death cases than in wave 1, UAE, and Spain. The death cases as a percentage of the total number of confirmed cases in wave 1 was much higher than that in wave 2. Some countries had waves 3 and 4. Waves 3 and 4 were had lower confirmed cases than wave 2, however, the death cases were variable in different countries. The death cases in waves 3 and 4 were similar to or higher than wave 2 in most countries. Wave 2 of COVID-19 had a much higher spread rate but much lower severity resulting in a lower death rate in wave 2 compared to that of the first wave. Waves 3 and 4 had lower confirmed cases than wave 2; that could be due to the presence of proper treatment and vaccination. However, that was not reflected in the death cases which were similar to or higher than wave 2 in most countries. Further studies are needed to explain these findings.

Fuente: Journal of Medical Virology

Published: 24 August 2021

Ingresar